Hypertensive Encephalopathy Management

Definition and Epidemiology

Hypertensive encephalopathy is a hypertensive emergency characterized by severe blood pressure elevation associated with neurological symptoms, including seizures, lethargy, cortical blindness, or coma, in the absence of alternative explanations, as defined by the European Society of Cardiology 1, 2
The diagnosis does not depend on specific blood pressure thresholds—the rate of BP rise matters more than absolute values, according to the European Heart Journal 3
Hypertensive encephalopathy occurs in 10-15% of patients with malignant hypertension, as reported by the European Heart Journal 1
Up to one-third of patients may lack advanced hypertensive retinopathy, making neurological symptoms and imaging the primary diagnostic criteria, as noted by the European Heart Journal and other sources 1, 4

Key neurological manifestations to identify include seizures, altered mental status, cortical blindness, severe headache, visual disturbances, and somnolence preceding loss of consciousness, as described by the European Heart Journal 1, 2, 3
Focal neurological deficits are rare in hypertensive encephalopathy, and their presence should raise suspicion for intracranial hemorrhage or ischemic stroke instead, as stated by the European Heart Journal 3

History must focus on onset and duration of symptoms, medication non-adherence, and use of BP-elevating drugs, as recommended by the European Heart Journal 3
Physical examination priorities include BP measurement in both arms and lower limb, cardiovascular assessment, neurological examination, and fundoscopy, as outlined by the European Heart Journal 1, 3
Essential laboratory tests include hemoglobin, platelet count, creatinine, sodium, potassium, lactate dehydrogenase, haptoglobin, urinalysis, and ECG, as specified by the European Heart Journal and Hypertension 2, 3, 5
MRI with FLAIR sequences is the diagnostic imaging of choice to demonstrate increased signal intensity in posterior white matter regions, confirming posterior reversible encephalopathy syndrome (PRES), as recommended by the European Heart Journal 3

All patients with hypertensive encephalopathy require ICU admission with continuous BP monitoring, as stated by the European Society of Cardiology 5
Reduce mean arterial pressure (MAP) by 20-25% immediately within the first hour, as recommended by the American Heart Association and the European Society of Cardiology 2, 4, 5
Labetalol is the first-line agent for hypertensive encephalopathy, with a dosing regimen of 20 mg IV over 2 minutes, repeat 20-80 mg every 10 minutes up to total dose of 300 mg, as specified by the European Society of Cardiology 4, 6
Alternative agents include nicardipine and clevidipine, as noted by the European Society of Cardiology 5, 6
Avoid short-acting nifedipine due to unpredictable BP drops and reflex tachycardia, as warned by the European Society of Cardiology 5

With prompt recognition and appropriate treatment, hypertensive encephalopathy is fully reversible, as reported by the European Heart Journal 3
Without treatment, hypertensive emergencies carry a 1-year mortality rate >79% and median survival of only 10.4 months, as noted by the European Society of Cardiology 5